Skip to content

Normative Database for Gait Analysis on the GRAIL UZ Gent

Normative Database for Gait Analyses and Balance on the GRAIL at the University Hospital of Ghent.

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04987346
Enrollment
240
Registered
2021-08-03
Start date
2021-07-14
Completion date
2026-01-01
Last updated
2023-11-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gait

Keywords

Gait analysis, Control group, Healthy, Reference data, Kinematics, Kinetics, EMG, Dual-tasking

Brief summary

The aim of this study is to collect a large set of norm/control data on an instrumented treadmill (the Gait Real-time Analysis Interactive Lab - GRAIL) at the university hospital of Ghent for the purpose of clinical studies as well as for clinical interpretation. We hypothesize that this norm/control data will provide reference data of the normal gait patterns in the healthy population such that we can then use it to identify gait abnormalities in populations with pathology. The following data will be collected on the GRAIL while subjects walk at different gait speeds: 3D kinematics, kinetics, and EMG. Additionally, 3D kinematics, kinetics, and EMG data will be collected when performing either a cognitive (Stroop Color and Word Test) or motor (requiring arm swing) dual-task while walking at comfortable walking speed.

Interventions

OTHERWalking on an instrumented treadmill

Participants will be asked to walk at different gait velocities for 1 minute. The treadmill speed will be increased incrementally at 0.1m/s intervals until just before running.

OTHERWalking on an instrumented treadmill while dual-tasking

Participants aged between 6 and 17 years will be asked to walk at comfortable walking speed while playing either a cognitive (Stroop Color and Word Test) or motor (requiring arm swing) game.

Sponsors

University Ghent
CollaboratorOTHER
University Hospital, Ghent
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
6 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

\- Healthy participants

Exclusion criteria

* They suffer from neurological disorder * Have balance problems * Take medications that affect gait and balance * Have undergone surgical procedures on the lower limbs in the past * Experience pain in their lower limbs or back at the time of test taking.

Design outcomes

Primary

MeasureTime frameDescription
EMGsingle point assessment in 1 dayMuscle activity of 32 lower and upper limb muscles (micorvolts)
Kineticssingle point assessment in 1 day3D kinetics of lower limb joints while walking (Nm)
Kinematicssingle point assessment in 1 day3D kinematics of lower and upper limb joints while walking (degrees)
Spatiotemporal parameterssingle point assessment in 1 daySpatial parameters (m)
EMG synergiessingle point assessment in 1 daySynergy analysis will be carried using the EMG data (variance accounted for -VAF)

Secondary

MeasureTime frameDescription
Gait deviation indexsingle point assessment in 1 dayBased on kinematics, the lower-limb gait deviations will be calculated (degrees)
Game result (cognitive task)single point assessment in 1 dayScore (% correct)
Game result (motor task)single point assessment in 1 dayScore (% correct)

Other

MeasureTime frameDescription
Developmental Coordination Disorder Questionnaire (DCDQ)single point assessment in 1 dayBrief parent questionnaire to screen for coordination disorders in children
M-ABC-2single point assessment in 1 dayStandardized tool to indentify motor functioning in children
segment lengths (cm)single point assessment in 1 dayanthropometric data
weightsingle point assessment in 1 dayanthropometric data
height (cm)single point assessment in 1 dayanthropometric data
Demographic datasingle point assessment in 1 dayGender, age

Countries

Belgium

Contacts

Primary ContactAnke Van Bladel, PhD
Anke.VanBladel@UGent.be093321243

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026